Anbogen Secures 12.5 Million in Series A Funding, Advancing Precision Oncology Drug Development
/PRNewswire/ -- Anbogen Therapeutics, a clinical-stage biotechnology company specializing in groundbreaking cancer drug development, today announced the...
Source: prnewswire.com